Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Subject Index for Volume 30
discontinuation, effects on osteomalacia 318excretion in pig (abst) 975not induce uremic osteomalacia (abst) 130
134 stainable reflects bone histology 717toxicity in hernodialysis (abst) 978
Aminophylline and caffinc (abst) 45Ammonia production, PST 340Amphotericin B
amphotericin B methylester, brush border membrane. . 311546 Ampicillin & gentamicin, pyclonephritis 481
Amyloid protein, B2—microglobulin 385Amyloidosis
renal tubular function in (ahst) 634Analgesic
phenacetin, papillary necrosis, CaP 81701 Analysis
cell culture approaches in glomcrular inflammation 246micro method to measure PAH and creatinine 113electrophysiological 216
Anaphylatoxin C3a, C5aartificial kidney, compartmental distribution of 74
Anaphylatoxin C5a, hemodynamics 62Angiotcnsin II
905 control of baroreflex sensitivity (abst) 622299 cortical gradient (abst) 628640 norepincphrine on afferent aterioles 894474 plasma antidiurctic hormone and water excretion 503835 role in overt functional proteinuria 538355 Anorexia nervosa, potassium homeostasis 116355 Anti-GBM antibody633 induced alterations in glomerular permselectivity 666630 Anti-GBM-GN129 mernbranous transformation (ahst) 620974 Anti-inflammatory drugs453 nonsteroidal in CRF 760628 Antibodies
anti-tubular basement membrane TIN (absi) 614cellular immunity, experimental strategies 264coated bacteria, UTI (abst) 458
355 HLA sensization and transplantation (absi) 131977 immunoelectron microscopy in research 229656 kinetics of circulating and splenic (ahst) 614488 quantitation of components of' glomerular immune de-
posits raised lgA anti-pneumococcal (abst) 629splenic PFC assay (abst) 618study of kidney cells in culture 208
Anticystinuric effect of glutamine(ahst) 456Antigen
binding to immune complex deposits 706DR distribution in glomerular disease 128functional identity in Goodpasture's 128glomerular, monoclonal antibodies 649
(3oodpasture in Alport's syndrome 107
Heymann Nephritis, biochemical investigation of 9identification in GN (abst) 619macrophage differentiation on mesangial cells (abst) ... 613
major histocompatibility, role in transplantation
xvi
Aboriginal subjectsrenal disease, IgA nephropathy (abst) 627urinary tract disease (abst) 627
Acetate, serum in hypotension (abst)Acidification
distal, furosemide test (abst) 130impaired renal, acute renal ischcmia 905renal, dietary sodium role 43segmental characterization of defects in collecting
tubuleAcidosis
maleic acid-induced lysozymuria 803metabolic, bone formation 69402 during acidosis (abst) 132
Acidspolyunsaturated fatty, fibrinolytic activity in glomeruli
Acquired renal cystic diseaseclinical characteristics 748
ACTH, renal effects in man (ahst) 621Acute acid pH
glutamine transport in proximal straight tubule 340Acute filtration failure (abst) 622Acute renal failure
acidification following ischemiadietary protein prior to renal ischemiadrug associated (abst)endotoxin-induccd, thromboxane A2 and leukotrienesglomerular response to vasoconstrictor agentshemorrhagic hypotensionhemorrhagic hypotensionin elderly (abst)non-Hodgkin's lymphoma (abst)prognostic patterns in 1,000 episodessurvival after (abst)value of renal biopsy (abst)worsened by phosphate depletion (abst)
Acute renal insufficiencylegionaires disease (abst) 455
Acute tubular necrosishemorrhagic hypotension
Acute vasomotor nephropathy (abst)Adenosine elevation, GFRAdriamycin glomerulopathy, lesionsAged
causes of ARF in (abst) 633Albumin, nephropathy (abst) 618Aldosterone
insulin responses to potassium infusion 882Allograft
improvement in early function with verapamil 615role of major histocompatibility antigens in transplanta-
tion 1
Alphaketoisocaproate, protein synthesis 890Aluminum
affinity constants for, and transferrin (ahst) 617chronic heniodialysis population (ahst) 633deferoxamine to remove 943desferrioxamine effect on, in bone 68
Subject Index: Vo/. 30 Xvii
monoclonal antibodies to non-GBM capillary wall(abst) 613
Antithrombotic activity of GBM (abst) 631Aoritc reconstruction 975Arginine vasopresin
modulates Na+ ,K+ cotransport system (abst) 131Arterial hypertension in PHP (abst) 133Arterio-venous fistulas
detection of (abst) 129Articular amyloidosis
B2M in hemodialysis (abst) 642Artificial kidney
complement activation products 74Atrial natriuretic facotr
hemodynamic effect (abst) 133vasopressin release (abst) 621
Atrial natriuretic peptideblood levels, endocrine and excretory effects of Na
(abst) 459effects of, on kidney function in man (abst) 455enhancement of renal effects (abst) 621essential hypertension (abst) 634may increase plasma insulin in man (abst) 458release in man (abst) 457release with volume change in CRF (abst) 621renal action of, during glomerular filtration 16synthetic, plasma arginine-vasopressin level (abst) . . . . 454
Autoimmune nephritis (abst) 639Azotemia during hemodialysis 605
B cell crossmatch, HLA-DR in graft(abst) 454Baroflex sensitivity, All (abst) 622Basement membrane antigens 649Basolateral membranes
experimental diabetes on insulin binding 348high NaCI diet, effect on Na+ extrusion in rat
kidney 518Beer drinker, hyponatremia (abst) 640Bence Jones proteins, administration 873Benzolamide, peritubular capillaries 827Binding, antibody, component of deposits 255Biochemistry, isolation, use of nephron 201.Biopsy
renal disease in diabetics (abst) 617T cell subsets (abst) 974value of renal in ARF (abst) 453
Bloodserotonin, role of prostaglandins and SHT-2 receptor .. 304
volume and pressure, plasma protein 730Blood pressure
hemodynamics of calcium channel blockers (abst) 130sympathetic nervous system in hypertension 437
BoneCAPDdesferrioxamine effect on aluminum in bonedietary phosphorus and calcium in hemodialysisdiscontinuation of Al exposure, effect on osteomalacia.hyperaluminemia (abst)lead intoxication (abst)metabolic acidosis 694stainable Al reflects histology 717
Brush border membraneamphotericin B and amphotericin B methylester 311Heymann Nephritis, biochemical investigation of 9light chain effects 662
tetraethylammonium transport (abst) 457B2 microglobulin
diagnose tubulo-interstitial renal lesions in children. . . . 91amyloid protein associated with chronic hemodialysis. . 385
Caffeine and aminophylline (abst) 455Calcitonin
PTH, Ca and magnesium transport (abst) 621Calcitriol levels in CRF (abst) 619Calcium
channel blockers, effects on BP and hemodynamics(ahst) 130
diet in calcium stone former (abst) 641dietary phosphorus and, in hemodialysis patients 753urinary Ca-citrate index for nephrolithiasis 85
l,25(OH)2D3, response of hypertensive rats 497Calcium stone former
citrate and pyrophosphate inhibitors (abst) 974Canada
pediatric renal transplants S-3lCancer
neoplasia and glomerular injury 465renal pelvic, phenacetin and papillary necrosis 81
CAPDbone disease 379catheter related complications (abst) 459CCPD in children S-7ceftazidime (abst) 642CNS function in hemodialysis 956compared with hemodialysis in children S-Illong-term treatment (abst) 132
opsonic deficiency (abst) 976peritoneal dialysis, nutrition 617peritonitis, biological examination (abst) 455polysulfone hemofilter, gentamicin and
phenytoin sieving 936prevention of peritonitis, Y-connected double bag
(abst) 459sodium hypochiorite vs. povidone-iodine (abst) 976trace elements in serum, packed cells and dialysate . . . 599
Capillaryperitubular forces 827
Captoprilpotassium tolerance (abst) 627
Carbonic anhydrase inhibitor, capillary 827Carcinoma
analgesic nephropathy (abst) 641Cardiac failure, CyA nephrotoxicity 963Carpal tunnel syndrome
B2—microglobulin: new form of amyloid protein,hemodialysis 385
hemodialysis (abst) 642Catecholamine in ischemia (abst) 458
in renal failure (abst) 626in uremics 566
CatheterCAPD complications (abst)subclavian, hemodialysis accessTenckoff alternative (abst)
Cefotaxime in CAPD peritonitis (abst)Ceftazidime in CAPD (abst)Cell
continuous measurements of volume changes in singletubules 187
electrophysiological analysis of transport 216
37968
753318638632
459975976625642
xviii Subjeut Index: Vol. 30
epithelial, C3 receptors . 851glomerular immune deposits, quantitation of compo-
nents 255glomerular inflammation, culture approaches 246imaging renal tubule, methods 192immunity, experimental strategies for study 264isolation and use of specific nephron segments, bio-
chemical 201studies of kidney cells in culture 208
Cellular energetics, hypotension 55Central nervous system in CAPD and HD 956Cephalothin & gentamicin, pyelonephritis 481Child
B2 microglobulin to diagnose lesions 91CAPD/CCPD in S-7chronic renal program assessment (abst) 977comparison of CAPI) and hemodialysis in . . S-I I
cyclosporine in transplantation S-35FOS recurrs in children following transplantation S-44FSGS following renal transplantation S-44isolated heinaturia (abst) 636membranous nephropathy (abst) 975nutrition therapy in renal disease S-3pathophysiology of growth failure in CR1 -59recurrence of H1JS in transplant recipients S-SIresults in renal transplantation at Univ of Minnesota . . S-25
Chlorpropamide, loop of Henle 712Chromatography
quantitation of components of glomerular immunedeposits 255
Chronic renal failureatrial natriuretic peptide (ahst) 621beta blockade (abst) 976calcitriol levels in moderate (abst) 619desferrjoxamine effect on aluminum in bone 68dietary management in children (abst) 624energy expenditure 741energy expenditure 741hyperoxaluria (abst) 635induce experimental, by cryosurgery 433physical conditioning (ahst) 458quality of life for child (abst) 977renal transplantation in children -25verapamil slows pregression of (ahst) 619
Chronic renal insufficiencydigitalis-like factors in 723growth failure S-59nutrition therapy in children S-3pathophysiology of growth failure S-59
Chronic serum sickness 706Ciminobrescia arteriovenous (abst) 635Circadian, brush border enzymes (absi) 639Circulating immune complex (abst) 619Cirrhosis
factors determining renal response to water immersion. 417interstitial pressure dynamics (abst) 132peritoneovenous shunt in hepatorcnal syndrome 736
Clearance, renalisolated perfusion techniques 142
Colchicine, proteinuria in HN (abst) 977Collagen, type IV
age and diabetes in human kidney cortex 586Collecting tubule acidification 546Colloid osmotic pressure, protein 730Complement
CS, glomerular lesions 678role of, in neutropenia (abst) 455
Computerhandling of clinical data for dialysis (abst) 135
Conductance, (CO2 - 1C03) electrical 325Cortex
age and diabetes on type IV collagen and laminin 586transport in plasma membrane vesicles isolated from
renal 171Cortical gradiant in All receptor (ahst) 628Cortical thick ascending limbs
conductance, (CO7 + 1-1C03)Cost of ESRI) therapy (abst) 459Cotransport
AVP modulates Na ,K (abst) 131
Cryosurgerymethod to induce chronic renal failure by 433
Culturecell, analysis of glomerular inflammation 246kidney cells in 208
Cushingold features in children S-35Cutaneous hypersensitivity in ESRD(ahst) 454Cyclosporine
allograft function (abst) 637Australian multicenter trial (ahst) 614conversion from azathioprine (abst) 634current state of renal transplantation -23hypertensive effect in sheep (ahst) 620idiopathic nephrotic syndrome (ahst) 640indium-Il l—oxine platelets, allograft rejection (absi) . . . 129mechanism (abst) 621nephrotoxicity 963renal transplantation in children S-35tolerance assessment in renal transplant (abst) 129treatment in renal transplantation, azathioprine (abst). . 130
Cylinduria induced by lriamterene (abst) 616Cyst
method to study human polycystic kidney disease inculture 371
Cystic, acquired renal disease 748Cystitis (abst) 616C3
receptors on glomerular epithelial cells 851C3a. C5a in artificial kidneys 74C3b receptor
SLE nephritis (abst) 639C4, C4A and C4B complement detection 931CS mice, glomerular lesions 678CSa anaphylatoxin on hemodynamics 62CSh-9 complex, complement in humans 399
Dcferoxamineremoves Al in dialysis 943Al-induced osteomalacia 318
Dcndritic cell, lupus nephritis (abst) 6181)eposits, glomerular immune, analysis 225Desferrioxamine
abrogation of renal injury 613effect on aluminum 68renal injury 812
DiabetesESRD (ahst) 629experimental, insulin binding by basolateral
membranes 348glomerular pyrimidine nucleotide biosynthesis 27
Subject Index: Vol. 30 xix
proteinuria prevented by phosphate depletion (abst) . . . 623renal biopsy in (abst) 617
Dialysatetrace elements in serum, packed cells and, in CAPD
patients 599Dialysate buffer
hemodynamic instability during hemodialysis 605Dialysis
acetate and bicarbonate, plasma volume changes (abst) 635acquired renal cystic disease 748Al removal by deferoxamine 943biocompatibility (abst) 636body fat alterations in patients, glucocorticoids (abst). . 459CAPD/CCPD in children S-7computer handling of clinical data (abst) 135digitalis-like factors in hypertension and CR! 723discontinuation of Al exposure, osteomalacia 318home, hemasite (abst) 642leukopenia, artificial kidneys and C3a, CSa 74long-term CAPD treatment (abst) 132
opsonic deficiency (abst) 976pediatric, 10 year's experience S-ISre-transplantation (abst) 979recurrent FSGS in children following renal transplanta-
tion S-44results in pediatric renal transplantation S-25stainable Al reflects bone histology 717transplantation in children. cyclosporine S-35vitamin supplementation 99
Dialyzerhigh flux polysulfone hemofilter 429reuse in MHD (abst) 979
Dietblood pressure, fat, prostaglandin synthesis (abst)carbohydrate role in renal failurehigh protein vs. low in renal insufficiency (abst)improved management in children with CRF (ahst).K depletion a mechanism for extrarenal K adaptation.phosphorus and calcium in hemodialysisplasma protein, BP and blood volumeprotein prior to ischemia affects postischemic functionproteinuria (abst)therapy in childrenvitamin D3 mechanism
Diffuse pulmonary hemmorhage (abst)Digitalis-like factors in RIDiltiazem (abst)Distal renal tubular acidosisDiuresis, ANP (abst)DMSO
NSAIDs in Heymann's nephritis (abst)prevents glomerular injury (abst)
Dopamineand indomethacin in rabbit newborns (abst).responses of in vivo renal microvessels 361
DR antigens in glomerular disease 128
Drug associated ARF (abst)Dysplasia, renal failure (abst)
Eicosapentanoic acid, LN (abst) 629Electrical conductance, cTALH 325Electrophysiological index in CAPD, HD 956End-stage renal disease
Canada, pediatric renal transplantation -31CAPDICCPD in children S-7
Catalonia, Spain 128chilren management S-IFSGS recurrs in children following transplantation ... .S-44human polycystic kidney disease, method to study epi-
thelia 371pediatric hemodialysis, 10 years 5-15recurrence of HUS in transplanted children S-SIregistry of Andalusion region (abst) 132results in pediatric renal transplantation S-25
End-stage renal failurechronic effects of dietary protein 509course of lupus nephritis 978diabetes, Il years experience (abst) 629factors contribute to cost containment (abst) 459
Energyexpenditure in CRF
Enlapril and hypertension (abst) .Enzyme
brush border, circadian (abst)inhibition, transplantation (abst)
Epitheliacultured kidney cellshuman polycystic kidneyC3 receptors
Erythema, lupus nephritisExcretion
aluminum (abst)clearance and isolated kidney perfusion techniques. . . . 142desferrioxamine effect on aluminum in bone 68mineralocorticoid-stimulated renal acidification, sodium 43water, effect of vasopressin antagonist on 49
Failurelight chain effects on alanine and glucose uptake 662
Failure, renalaldosterone and insulin responses to potassium infu-
sion 882carbohydrate role in experimental 687stainable Al reflects bone histology 717
Familial gout, renal disease 280Fanconi syndrome 662
lysozymuria and lysosomal enzymuria, maleic acid. . . . 803975614701280192894488
Gas, pulmonary exchange during HD 919Gentamicin
high levels in E. coli pyelonephritis 481
phenytoin sieving, polysulfone hemofilter 936Glomerular
immune deposits, quantitation of exogenous andendogenous 255
pyrimidine nucleotide biosynthesis in isolated glomeruli 27
741623
639638
208371851769
623687634624532753730299631S-3792135723977
Fiberoptic bronchoscopy (abst)Fibrin deposition in GN (abst)Fibrinolytic activity in glomeruliFibrosis, gouty nephropathyFlourescent probe, imaging methods
546 Focal constriction, All, norepinephrine455 Focal sclerosis, lesions
Focal segmental sclerosischildren following renal transplantation
Food hypersensitivityimmune complex glomerulopathy in child with 592
Furosemidedistal acidification values 130
453
S-44
640637
requiem for gouty nephropathy 280
XX Subject lnde: Vol 30
631293841229
27
53816
760509142656
458280280129
624841
642
Glomerular basement membraneantithromhotic activity, ADPasc (abst)biochemical advancesimmune complexes, heparan sulfate-proteoglycansimmunoelectron microscopy in kidney researchpyrimidine nucleotide biosynthesis in isolated glomeruli
Gloincrular filtration rateangiotensin 11 in proteinuriaatrial natriuretic peptide renal action during control ofchronic dosing of NSAIDschronic effects of dietary proteinclearance and isolated perfusion techniquesintrarenal adenosine elevationleukotriene C4 and D4 contract rat glomerular mesan-
gial 524nutrition therapy in renal disease S-3renin release mediated by tubular flow rate 32
Glomeruliimmunoelectron microscopy in kidney research 229inflammation, cell culture approaches to analysis 246isolation and use of specific nephron segments and
cells 201respones of microvessels to dopamine 361
Glomerulonephritisanti-GBM induced alterations in permselectivity 666diffuse mesangial proliferative (abst) 979diffuse proliferative, macrophages (abst) 613diffuse pulmonary hemmorhage (abst) 135
fibrin deposition (abst) 614H deficiency 948idiopathic membranous, 144 cases (ahst) 624immune complex induced, lesions in mice 678lymphokine production (abst) 618lymphokine production by glomerular T-lymphocytes.. 673membranous, neoplasis and glomerular injury 465quantitation of immune deposits 255serum sickness, immune complex disease 706
Glomcrulopathyminimal change. 40 patients, 16 years 975
Glomerulusangiotensin II and saralasian 56
G lucocort icoidaltered skeletal muscle in transplant patients on predni-
sone 411
dialysis (ahst) 459Glut amine
anticystinuric effect (abst) 456transport in proximal straight tubule, acute acid pH . . . 340
Goodpasture's antigenidentity between renal and pulmonary 128
Goodpasture's syndromeimmunosuppression, plasmaphercsis (ahst)
Gout, nephropathyGouty nephropathyGranulocyte elastase plasma level (abst)Growth
CAPD/CCPD in children S-7comparison of CAPD and HD in children -11
immune complex glomerulopathy, food hypersensitiv-ity 592
pathophysiology in chronic renal insufficiencypediatric hemodialysis, 10 years S15study of kidney cells in culture 208
Gut peptide, natriuretic action (ahst) 627
H deficiency, intramembranous deposit 948Heart failure, congestive
role for AVP and water excretion 49Heart transplant
volume load (ahst) 641Hematuria
IgA sequential study 923isolated, 65 children (abst) 636macroscopic, tonsillectomy (ahst) 134severe loin pain (abst) 615
Flemmorrhage, cryosurgery and CRF 433Hemodialysis
access with subclavian catheters (ahst) 975aluminum levels in population (abst) 633amyloidosis and B,M (ahst) 642hiocompatihility (abst) 636carpal tunnel syndrome (abst) 642chronic, B2—microglobulin: amyloid protein associated
with 385chronic, without vitamin supplementation 99CNS function in, and CAPD 956compared with CAPD in children S-I Icomparison with CAPD in children -Ilcomputer modeling of volume changes (abst) 453dialyzer reuse (abst) 979dietary phosphorus and calcium 753granulocyte elastase plasma level (abst) 129hemasite, home (abst) 642hernodynamic instability during 605iron overload (abst) 974plasma free, sulfo-, glucuroconjugated catecholamines. 566pulmonary gas exchange during 919Redy sorheni system (abst) 625sexual dysfunction (abst) 617survival after ARF (abst) 974toxicity of Al (abst) 978uremia on Na,K cotransport system (ahst) 130
Hemodialysis, homenutrition (abst) 618
Hemodialyzerartificial kidneys, C3a and CSa 74
Hemodynamicsangiotensin It 503glomerular, C5a 62
Hemofilterhigh flux polysulfone 429polysulfone, gentamicin and phenytoin sieving 936
Hemolytic uremic syndromerecurrs in renal transplantation 5ltreated with cyclosporine, plasmapheresis therapy
(abst) 456Henle
loop flow rate, renin 332Henoch Schonlein nephritis
outcome of patients (abst) 624retrospective review (abst) 624(abst)
Heparan sulfate-proteoglycansHepatitis B
uremic patients (abst)vaccination, transplants 453virus, transplant (abst) 453
Hepatorenal syndrome, shunt 736Heymann Nephritis
biochemical investigation of pathogenesis of 9
Subject index: Vol. 30 Xxi
colchicine reduces proteinuria (abst) . 977immunoelectron microscopy in kidney research 229DMSO and NSAIDs (abst) 978monoclonal antibodies 649
High flux polysulfone hemofilter 429High risk population, tenoxicam (abst) 454Hippurate, plasma ligand binding 391HLA-DR in graft recipient (abst) 454Hodgkin's disease
neoplasia and glomerular injury 465Homeostasis
extrarenal potassium 116
posassium (abst) 627Hydrocarbon exposure, MG (ahst) 628Hypomagnesuria (abst) 641
Hyponatremiabeer drinker (abst) 640
Hypotensionhemodynamic instability during hemodialysis 605hemorrhagic, acute renal failure 355serum acetate as factor in hemodialysis (abst) 134
Hypoxemia during hemodialysis 919Hyptertrophy
phosphatidylcholine metabolism in tubules (abst) 133
Idiopathic cardiomyopathy 963Idiopathic nephrotic syndrome
cyclosporine (abst) 640IgA mesangial GN
portal hypertension (abst) 640
IgA nephropathyaboriginal family (abst) 627
pregnancy 913raised IgA anti-pneumococcal antibodies (abst) 629
sequential study of system in relapsing 923shared idiotypes in patients (abst) 134T and B cells alterations (abst) 134
Immune complex 649deposits, direct antigen binding to 706glomerulopathy, food hypersensitivity 592
heparan sulfate-proteoglycans 841lesions in mice 678
Immunityexperimental strategies for study of cellular 264
Immunoblot analysiscirculating imniune complex constituent ID (abst) 619
Immunoelectron microscopy in research 229lmmunosuppression
current state of trnasplantation S-23cyclosporine in transplantation in children S-35major histocompatihility antigens in transplantation . . .
therapy in renal transplantation (abst) 456Indapamide (abst) 977Index, urinary calcium-citrate 85Indium-Il 1—oxine leukocytes (ahst) 129Indomethacin
and dopamine in rabbit newborns (abst) 453final outcome on nephrotics (abst) 636pharmacokinetics (abst) 632
Infantsnephrocalcinosis (abst) 629
Inflammation, glomerular, cell culture 246inhibitors of plasma ligand binding 391
Injury
B2M to diagnose tubulo-interstitial lesions in children. . 91
DMSO prevents glomerular (abst) 977experimental strategies for study of cellular immunity. . 264glomerular inflammation, cell culture approaches to
analysis 246
glomerular, neoplasia 465hydroxyl radical mediation by desferrioxamine 812hydroxyl radical mediation of immune renal (abst) . . . . 613leukotriene C4 and D4 contract glomerular mesangial
cells 524monoclonal antibody identification in lupus nephritis .. 573
platelet cationic proteins in lupus nephritis patients 555Insulin
atrial natriuretic peptide may increase plasma (abst). . . 453binding, experimental diabetes effect on 348
Interstitial pressure, cirrhosis (abst) 132Intestinal resistance to I ,25(OH)2D3 497Intestine, vitamin D3 mechanism 792Intramembranous deposit disease 948ion-selective microelectrode technique
electrophysiological analysis of tubular transport 216
lopamidol, nephrotoxic potential (abst) 976Iron
overload in CHD (abst) 974Ischemia
catecholamines in experimental (abst) 458
dietary protein prior to renal 299glomerular responses to vasoconstrictor agents in ARF 835impaired renal acidification 905thromboxane A2 and leukotrienes in ARF 474triple therapy in graft recipients (abst) 977
Isograftbilateral native nephrectomy improves function of . . . . 20
Isolated perfused tubuleindomethacin (abst) 632
Kidneyfunction, clearance and isolated perfusion techniques.. 142
Lactateacute hypoxic acidosis (abst) 13207 during acidosis (abst) 132
Lamininage and diabetes on type IV collagen, human kidney
cortex 586Lead
intoxication (abst) 632intoxication (abst) 629nephropathy, gouty nephropathy 280
Lectinisolation of specific nephron segments and cells 201
Legionaires disease, renal (abst) 455Lesion
adriamycin glomerulopathy 488B2 microglobulin to diagnose in children 91carbohydrate role in renal failure 687cell culture approaches to glomerular inflammation. . . . 246chronic progressive, lithium (abst) 626hyperplasia and atherosclerotic (abst) 626immune complex induced in CS mice 678
lupus glomerular, plasma exchange (abst) 616reversibility of urinary tract abnormalities 582SLE clinical course 976
Leucocyteanti-GBM antibody, permselectivity 666 passenger dependent, allograft survival (abst) 635
xxii Subject Index: Vol. 30
Leukemianeoplasia and glomerular injury 465
Leukopeniavcrapamil blunted (abst)
Leukotriene(24 and D4, mesangial cellsthromboxane and, in endotoxin-induced ARF
Ligandbinding by uremic plasma (abst)plasma binding, inhibitors of
Light chainalanine and glucose uptake
Light microscopic study. imaging methodsLithium
chronic progressive renal lesions (abst)clearance, sodium handling (absi)
Livervitamin D3 metabolism and mechanism
LLC-PKI, transport of TEA (abst)Loop of Hcnle, chiorpropamideLumen obstruction, morphologyLupus nephritis
clinical-pathological correlation (ahst)clinico-pathological parameters (abst)course on dialysis (abst)dendritic cell accumulation (abst)cicosapentanoic acid (abst)platelet cationic proteins in glomeruli of.treatment ofurinary sediment analysis (abst)
Lymphocytes, cellular immunity, diseaseLymphokine
production by T-lymphocytes (abst)production
Lymphoma, non-Hodgkin's (ahst)Lysozymuria, maleic acid
Macrophagedifferentiation antigens on mesangial cells (abst)diffuse proliferative GN (abst)
Magnesiumdeficiency of vitamin D (abst)
Maleic acidelevation of intrarenal adenosine, CJFR & renin releaselysozymuria, enzymuria
Ma nnitolprevention of ARI after transplantation (abst) 637
Matrices, connective, C5b-9 complex 399Measurement
continuous, of ccl volume changes in single kidney RI-bules 187
clectrophysiological analysis of tubular transport 216electrophysiological analysis of tubular transport 216renal clearance and isolated kidney perfustion tech-
niques 142
single tubule perfusion techniques 166Membrane
secondary, formation of high flux polysulfonehemofilter 429
transport studies in vesicles isolated from renal cortex . 171
Menihranoprolifcrative glomerulonephritispregnancy 913
Membranous
glomerulopathy, hydrocarbon exposure (ahst) 628nephropathy, childhood (abst) 975
transformation (ahst) 620Mesangial
(24, C4A and C4B complement detection 931134 cells cultured on rubber 861
Icukotriene C4 and D4 524Mesangial proliferative GN
clinical features (absi) 979Metabolic acidosis, bone formation 694
616 Metabolic rate, renal and NMR 35391 Methylester, amphotericin B 311
Microcirculation, All and saralasin 56662 Microdissection in biochemical studies 201192 Microelectrode techniques
electrophysiological analysis of tubular transport 216626 Micropartition system633 measure para-amino hippurate and creatinine 113
Micropuncture techniques 152792 Microscopy454 immunoelectron, in kidney research 229712 Microvessels, responses to dopaniine 361817 Mineralocorticoid
stimulated renal acidification, dietary sodium 43629 Minimal change glomerulopaihy616 16 years, 40 patients (absi) 975978 Minimal change nephrotic syndrome618 mononuclear blood cells (abst) 633629 Monoclonal antibodies555 antigen identification (abst) 619769 C4, C4A and (2411 complement detection 931639 Goodpasture antigen in Alport's syndrome 107265 identification of glomerular antigens 649
to non-glomerular basement membrane capillary wall . . 613618 Mononuclear673 minimal change nephrotic syndrome (ahst) 633630 Mononuclear803 associated with glomerular rejection (abst) 625
leukocytes, lupus nephritis 573phagocytes, peritonitis in CAPD (ahst) 637
613 Morphine elimination (abst) 620613 Multiple myeloma
Bence Jones proteins 873133 light chain effects on alanine and glucose uptake 662
Muscle656 altered skeletal, prednisone 411803 Myeloma
multiple, pattern in initial renal failure 129
Na, K-ATPasecirculating inhibitors of, osmolality (ahst) 622
Na-pump, effect of high NaCI diet 518Natriuresis
atrial natriuretic peptide renal action during GFR 16Necrosis
acidification following ischemia 905phenacetin and papillary 81renal papillary (abst) 616
Neoantigen, C5h-9 complex 399
Neoplasiaand glomerular injury 465acquired renal cystic disease 748
Nephrcctomybilateral native, improves renal isograft function 20dietary protein effects 509K depletion, mechanism for extrarenal K adaptation. . . 532
Nephrilis
524474
Subject Index: Vol.30 Xxiii
complement in heterologous phase of (abst) . 631
familial, Goodpasture antigen in Alport's syndrome . . . 107Henoch Schonlein (abst) 624Heymann, biochemical investigation of pathogenesis of 9idiopathic membranous glomerulo-, 25 years (abst). . . . 624lupus, clinical-pathological correlation (abst) 629lupus, monoclonal antibody identification S73
lupus, platelet cationic proteins in 555lupus, treatment of 769
Nephritogenic immune response 264Nephrocalcinosis, infants (abst) 629Nephrolithiasis
urinary calcium-citrate index for evaluation of 85
N ephronisolation and use of specific segments and cellsisolation and use of specific segments and cellsmicropuncture techniquessingle tubule perfusion techniques
Nephropathyanalgesic (abst)goutyIgA shared idiotypes in serum (abst)IgA. study sequentiallymembranous, pregnancy
Nephrotic syndromechildren, prednisolone (abst)in children (abst)indomethacin (abst)
Nephrotoxicityamphotericin B and amphotericin B methylester, BBM. 311cyclosporine 963iopamidol (abst) 976
Nervous system, sympathetic 437Neutropenia, complement role in (abst) 455
Nicardipine, hypertension (abst) 623Nifedipine, renal failure (abst) 626N it rite
urinary infections (abst) 628Nocardiosis in transplantation (ahst) 978Norepinephrine
All effects on afferent arterioles 894Norniotensives in hypertensive families
sodium intake (abst)NSAIDs in renal insufficiencyNuclear magnetic resonance spectroscopy
determines renal metabolic rate in vivoNucleotide, pyrimidine biosynthesisNutrition
home HD (abst)therapy in renal disease
Obstructionproximal tubule morphology after
Optical, microelectrode study methods .Osmolality, Na,K-ATPase (abst)Osteodystrophy
CAPD and bonechildren, CAPD/CCPD
Osteomalaciadiscontinuation of Al, effects onmetabolic acidosis on bone formation.
Oxigen, free radical & BP (ahst)
P-aminophenol, filtration failure (abst) 622Packed cells, trace elements in CAPD 599
Para-amino hippurateand creatinine, micro-method to measure 113
Paracetamol, necrosis, cancer (abst) 616Parathyroid activity in children (abst) 619Parathyroid hormone
calcitonin, Ca and magnesium transport (abst) 621in chronic hyperparathyroidism, bicarbonate (abst) 456
Parenchyma, renal, carbohydrates in 687Pediatric
dialysis S-7hemodialysis, 10 years S-15renal transplants., Canada S-31
Pelvic cancer, necrosis 81
Peptideatrial natriuretic, in sheep (abst) 621atrial natriuretic, renal action during control of GFR... 16gut (abst)
Perfusionisolated kidney, techniques
641 techniques, single tubule280 Peritoneal dialysis134 nutritional assessment of CAPD (abst).923 Peritoneovenous shunt in HRS913 Peritonitis
CAPD (abst)639 CAPD/CCPD in children978 CAPD, exam (abst)636 cefotaxime in CAPD associated (abst)
prevention during CAPD (abst)Permeability, collecting duct (abst)Permselectivity
electricial conductance 325
glomerular 666pH
acute acid, glutamine transport in proximal straighttubule 340
Pharmacological synergygentamicin in treatment of E. coli pyelonephritis 481
Phenacetin and papillary necrosis 81
Phosphatecitrate inhibitors in calcium stone formers 974depletion, proteinuria of diabetes mellitus 623
457 handling and PT in children (abst) 619760 restriction prevents hypercalcemia (abst) 628
Phosphatidyleholine, hypertrophy (abst) 133
Physical conditioning on ARF (abst) 45827 Physiology, renal
micropuncture techniques 152618 single tubule perfusion techniques 166S-3 Plasma
antidiuretic hormone, All 503(AVP) effect of antagonist on water excretion 49
817 exchange in treatment of lupus glomerular lesions192 (abst) 616622 impaired ligand binding by uremic (abst) 616
level (abst) 454ligand binding, inhibitors of 391
S-7 osmolality, stable during HD 605renin, chlorpropamide effect on loop of Henle 712
318 renal flow measurement techniques
694 systemic arterial; renin release131 Plasmapheresis
Goodpasture's syndrome (abst) 458therapy (abst)
Plasminogen activators in glomeruli
201201152166
142166
617736
637S-7455625459622
142
332
456701
xiv Author Index: Vol. 30
Vallo A (abst) 130Van Breda Vriesman PUC (abst) 635Van Damme B (abst) 636Van Der Straeten A See Verbeelen D et a! 68Van de Vyver FL (abst) 632van Bucket JH (abst) 637van Bronswijk H (abst) 637van Damme B (abst) 637van der Hem GK (abst) 632, 633, 634, 636van der Schueren M (abst) 636van Es A (abst) 636van Es LA (abst) 636, 637van Es PN (abst) 633Van Hoof I See Verbeelen D et a! 68van Hooff JP (ahst) 635Van Landschoot N (ahst) 632van Lier HJJ (abst) 637van Luyk WHJ (abst) 633van Renen MJ (abst) 624van Renterghem Leuven Y (abst) 637van Rijswijk MH (abst) 634van Valenberg PU (abst) 637van Zyl-Smit R (abst) 975Vandeputte M (abst) 636Vandonge R (abst) 626Vandongen R (abst) 623Vanholder R (abst) 632, 633, 635Vasmant D (abst) 639Veerkamp JH (abst) 636Veller MG (abst) 980Verbeelen D, Smeyers-Verbeke J, Van Hoof I, Van Der
Straeten A, De Roy G: The effect of desferrioxamineon concentration and distribution of aluminum inbone 68
Verbrugh HA (abst) 637Vercellone A See Camussi G et al 555Vergnaud M (abst) 642Verhoef I (abst) 637Veriava Y (abst) 979Vermey P (abst) 633Verpooten GA (abst) 632Verroust P. Ronco PM, Chatelet F: Monoclonal
antibodies and identification of glomerular antigens(Editorial Review) 649
Versluis DJ (abst) 634Viale I-P See Bouffard Y et a! 920Vickermann B See Capasso G et al 311Vidal C (abst) 128Vita A (abst) 128Vilella R (abst) 128Villafruela JJ (abst) 132Villamediana L (abst) 130Villamediana LM (abst) 132, 133VinayP(abst) 132Vining R (abst) 624Virto R (abst) 130, 131Vogt K (abst) 459von Graevenitz A (abst) 455Vriesendorp R (abst) 636
Wüst I (abst) 459Waer M (abst) 636Wakeford P (abst) 630Waib D See ROckel A et a! 429Walker BR See Henrich WL et a! 503
Walker LL (abst) 622Walker RG (abst) 626Walker RI (abst) 617, 621, 624Wallaeys B, Cornelis R, Mees L, Lameire N: Trace
elements in serum, packed cells, and dialysate ofCAPD patients 599
Walser M See Tungsanga K et a! 891Ward DM, Lee S, Wilson CB: Direct antigen binding to
glomerular immune complex deposits 706Ward MK (ahst) 131Waugh R (abst) 626Wauters JP (abst) 455, 459Weeden RP (abst) 632Weidmann P (abst) 454, 455, 458, 459Weimar W (abst) 634Weiner MW (abst) 627Weis S See Steinhausen M et at 56, 361Welch WJ, Ott CE, Lorenz JN, Kotchen TA: Effects of
chlorpropamide on ioop of Henle function andplasma renin 712
Wellard RM (abst) 622Wenting GJ (abst) 634Westenfelder C See Baranowski RL et a! 113White MG See Ramirez JA et at 753Whittembury G, Lindemann B, Carpi-Medina P,
Gonzalez E, Linares H: Continuous measurementsof cell volume changes in single kidney tubules 187
Whitworth JA (abst) 620, 621, 624Wiegman DL See Steinhausen M et al 56Wiggelinkhuizen I (abst) 976Wilhelm K-R See Steinhausen M et a! 56Wilicox PA (abst) 976Williams M (abst) 976Willink EJ (abst) 631Wilson CB (abst) 614Wilson CB See Pelayo IC et at 62Wilson CB See Ward DM et at 706Wilson G (abst) 976Wilson PD, Schrier RW, Breckon RD, Gabow PA: A
new method for studying human polycystic kidneydisease epithelia in culture 371
Wilson SK: The effects of angiotensin 11 andnorepinephrine on afférent arterioles in the rat 895
Winaver I, Agmon D, Harari R, Better OS: Impairedrenal acidification following acute renal ischemia inthe dog 906
Winter D (abst) 620Wipiler JE See Potter DE et al S-ilWirth H (abst) 457Wittmer H (abst) 979Wolcott D See Marsh iT et a! 957Wolff ED (abst) 631Wolfson M See Narasimhan N et al 748Wolthers BG (abst) 635Woo KT (abst) 616Wood CI (abst) 625Woodroffe AJ (abst) 624, 625, 629Woolfield NF (abst) 629Woolner DF (abst) 620Wright GF (abst) 620Wyndham RN (abst) 623
Yahay H See Freeman DM et at 35Yamada T See Gejyo F et at 385Yap L (abst) 130, 131
Subject Index: Vol. 30 XXV
carbonic anhydrase inhibitor 827Statistical report, ESRD in Catalonia 128Steroid resistent nephrotic syndrome
FSGS recurrs in children following transplantation. . . .S-44Steroid therapy in renal disease (abst) 624Sterol hormone action, vitamin D3 792Stone
calcium former (abst) 641uric acid nephrolithiasis managed with potassium
citrate 422urinary calcium-citrate index for nephrolithiasis 85
Suicidepediatric hemodialysis, 10 year's experience S-IS
Supramolecular architecture GBM 293Surgery, method to induce CRF 433Swan-Ganz catheterization 975
Systemic lupus erythematosisC3b receptor (abst) 639clinical course (abst) 976monoclonal antibody identification of mononuclear leu-
kocytes 573
T and B cellalterations in IgA nephropathy (abst) 134
Tcellcellular immunity in renal disease 264subset ratios for allograft survival (abst) 636subsets in biopsy material (abst) 974
T-lymphocytes in GN 673Tenckoff catheter (abst) 976Tenoxicam and renal function (abst) 454Tetraethylammonium transport (abst) 454Thick ascending limb of Henle
protein intake (abst) 638Thrombotic microangiopathy (abst) 614Thromboxane A2
leukotrienes in endotoxin-induced acute renal failure .. 474Thromboxane B2 in rejection (abst) 132TINU syndrome (abst) 638Tissue
culture analysis of glomerular inflammation 246damage, C5b-9 role in assessing 399GBM, advances in the biochemistry of 293
Tonsillectomy, hematuria (abst) 134Total lymphiod irradiation (abst) 636Transepithelial reabsorption of Na 518Transferrin, Al (abst) 617Transplantation
assessment of tolerance, CyA (abst) 129bilateral nephrectomy improves isograft function in rat. 20CAPD or HD, outcome of renal transplantation (abst) . 457current state of renal S-23CyA nephrotoxicity 963cyclosporin conversion (abst) 634cyclosporine experience, renal in children S-35cyclosporine treatment, change to azathioprine (abst). . 130de novo thrombotic microangiopathy (abst) 614FGS in children following renal S-44fiberoptic bronchoscopy (abst) 975graft loss, FILA and second transplant (abst) 131
heart (abst) 641hemodynamic alterations (abst) 638hepatitis B (abst) 453
hyperparathyroidism (abst) 615
immunosuppressive therapy (abst) 456
leucocyte, survival (abst) 635major histocompatibility antigens, role inmannitol (abst) 637multicenter report on CyA in Australia (abst) 614nocardiosis (abst) 978outcome after CAPD or HD (abst) 457patients on prednisone, altered skeletal muscle 411
patients on prednisone, impact of physical training(abst) 455
pediatric renal, Canadian perspective S-31
pregnancy (abst) 615recurrence of HUS in recipients S-51results in pediatric renal S-25risks of pregnancy (abst) 625secondary (abst) 979T cell subset ratios, survival (abst) 636triple therapy (abst) 977vaccination against hepatitis B virus 453
Transportchlorpropamide on loop of Henle 712comparative physiology (abst) 974continuous measurement of cell volume changes 187effects of (CO2 + HCO3) on electrical conductance,
cTALH 325electrophysiological analysis of tubular 216glutamine in proximal straight tubule 340kidney cells in culture 208mechanism, single tubule perusion techniques 166plasma membrane vesicles isolated from renal cortex. . 171
single tubule perfusion techniques 166TEA across BBM (abst) 457xipamid effect on Na,K (abst) 131
Triamterene induced cylinduria (abst) 616Trimethoprim
asymptomatic bacteriuria of pregnancy (abst) 617pyelonephritis 481
Tubularfluid flow rate, single nephron renin release 332micropuncture techniques 152renal function in amyloidosis (abst) 634
Tubuleblocked, morphology 817continuous measurements of cell volume changes in
single 187electrophysiological analysis of transport 216enriched suspensions in proximal and distal (abst) 133imaging renal cells, methods 192
immunoelectron microscopy 229
proximal straight, glutamine transport 340single, perfusion techniques 166
transport, comparative physiology 974Tubulo-interstitial lesions
adriamycin glomerulopathy 488B2 microglobulin to diagnose in children 91
Ultrafiltrationadvances is biochemistry of GBM 293
Uremiadrug protein binding (abst) 632hemodynamic instability during hemodialysis 605
Na,K cotransport in erythrocytes (abst) 130
secondary hyperparathyroidism, calcification (abst). . . . 131Uremic
alpha-ketoisocaproate for protein synthesis 890energy expenditure in CRF 741
XXVi Subject Index: Vol. 30
immune response to hepatitis B (abst) 642lymphocytes, prostaglandin inhibition (abst) 131
osteornalacia, Al (ahst) 130plasma free, sulfo- and glucure-conjugated catechola-
mines 566skeleton, CAPD 379
Uric acid nephrolithiasispotassium citrate in successful management of 422
Uric acid, gouty nephropathy 280Urinary infections
nitrite (abst) 628Urinary sediment analysis (abst) 639Urinary tract
abnormality, reversability 582disease, aboriginal subjects (abst) 627infection, ABC (ahst) 458infection, sexual (abst) 616
Vascular resistance, postglomerular 332Vasculature
All and norepinephrine 894renal and C5a 62
Vasoconstrictionadrenergic in human hypertensive kidney (abst) 633leukotriene C4 and D4 524loss of glomerular response after ARF 835
Vasopressinantagonist on excretion 49atrial natriuretic factor (abst) 621
pressor action of, in essential hypertension 128
release, angiotensin 11 503
Verapamilblunted leukopenia (abst) 134improvement of early renal allograft function (abst) ... 615slows CRF (abst) 619
Vesiclestransport studies in plasma membrane 171
VitaminD3 metabolism and mechanism 792supplementation, chronic hemodialysis without 99
Voltageelectrical conductance in cTALH 325
electrophysiologic analysis 216Volume
atrial natriuretic peptide release (abst) 457computer moduling of changes during hemodialysis
(abst) 453
Waterimmersion in non-excretor cirrhotic patients 417renal response factors in non-excretor cirrhotic
patients 417
Xanthyne Oxydase, blood flow (abst) 131
Xipamid, diuretic on transport (abst) 131
1,25(OH)2D3 792
magnesium deficiency (ahst) 133
response of hypertensive rats 497